FCGR3A Polymorphism Controls B-Cell Repopulation Kinetics in People With Multiple Sclerosis Treated With Ocrelizumab
Study Overview This study investigates the impact of the FCGR3A polymorphism on the kinetics of B-cell repopulation in individuals with […]
